Elelyso

Generic name: Taliglucerase Alfa
Drug class: Lysosomal enzymes

Usage of Elelyso

Elelyso is a man-made form of an enzyme that occurs naturally in the body. It is used as an enzyme replacement in adults and children at least 4 years old with Type I Gaucher disease.

Gaucher disease is a genetic condition in which the body lacks the enzyme needed to break down certain fatty materials (lipids). Lipids can build up in the body, causing symptoms such as easy bruising or bleeding, weakness, anemia, bone or joint pain, enlarged liver or spleen, or weakened bones that are easily fractured.

Elelyso may improve the condition of the liver, spleen, bones, and blood cells in people with Type I Gaucher disease. However, Elelyso is not a cure for this condition.

Elelyso side effects

Get emergency medical help if you have any signs of an allergic reaction to Elelyso: hives; difficult breathing; swelling of your face, lips, tongue, or throat.

Some people receiving a Elelyso injection have had a reaction when the medicine was injected, or up to 3 hours later. Tell your caregivers right away if you have:

dizziness or feeling like you might pass out;

chest tightness, wheezing;

swelling in your face;

cough, throat irritation;

flushing (warmth, redness, or tingly feeling);

nausea, vomiting; or

skin rash, itching, or redness.

Common Elelyso side effects may include:

headache;

rash, itching, warmth or tingly feeling;

dizziness or tired feeling;

nausea, stomach pain, vomiting; or

joint pain, back pain, pain in your arms or legs.

This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

Before taking Elelyso

You should not use Elelyso if you are allergic to taliglucerase alfa.

Tell your doctor if you are pregnant. It is not known whether taliglucerase alfa will harm an unborn baby. However, having untreated or uncontrolled Type I Gaucher disease during pregnancy may cause new or worsening symptoms in the mother, or complications in the baby such as growth problems or bleeding. The benefit of treating your disease may outweigh any risks to the baby.

It may not be safe to breastfeed while using Elelyso . Ask your doctor about any risk.

Relate drugs

How to use Elelyso

Usual Adult Dose of Elelyso for Gaucher Disease:

Therapy-naive patients: 60 units/kg via IV infusion (administered over 60 to 120 minutes) every other week Patients switching from Imiglucerase: -Patients currently being treated with imiglucerase for type 1 Gaucher disease can be switched to this drug. -Patients previously receiving a stable dose of imiglucerase should begin this drug at that same dose when they switch from imiglucerase to taliglucerase alfa. -Dose adjustments can be made based on achievement and maintenance of each patient's therapeutic goals. -A clinical study evaluated doses ranging from 9.5 to 60 units/kg IV every other week. Use: For long-term enzyme replacement therapy (ERT) for patients with cOnfirmed diagnosis of type 1 Gaucher disease

Usual Pediatric Dose of Elelyso for Gaucher Disease:

4 years or older: Therapy-naive patients: 60 units/kg via IV infusion (administered over 60 to 120 minutes) every other week Patients switching from imiglucerase: -Patients currently being treated with imiglucerase for type 1 Gaucher disease can be switched to this drug. -Patients previously receiving a stable dose of imiglucerase should begin this drug at that same dose when they switch from imiglucerase to taliglucerase alfa. -Dose adjustments can be made based on achievement and maintenance of each patient's therapeutic goals. -A clinical study evaluated doses ranging from 9.5 to 60 units/kg IV every other week. Use: For long-term enzyme ERT for patients with confirmed diagnosis of type 1 Gaucher disease

Warnings

Some people receiving a Elelyso injection have had a reaction when the medicine was injected, or up to 3 hours later. Tell your caregivers right away if you have a sudden headache, dizziness, warmth or tingling, chest pain, wheezing, nausea, or a red skin rash.

Elelyso is not a cure for Gaucher disease.

What other drugs will affect Elelyso

Other drugs may interact with taliglucerase alfa, including prescription and over-the-counter medicines, vitamins, and herbal products. Tell each of your health care providers about all medicines you use now and any medicine you start or stop using.

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.